MyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders at CommScope Holding Company, Inc. (COMM), LQR House Inc. (LQR), and MyMD Pharmaceuticals, Inc. (MYMD) have recently made significant share purchases. CommScope launched its SYSTIMAX Constellation edge-based platform, LQR House priced its IPO at $5.00 per share, and the FDA accepted MyMD Pharmaceuticals' investigational new drug application for a Phase 2 study.
August 25, 2023 | 1:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Director Claudius Watts IV acquired 10,000 shares of CommScope Holding Company, Inc. The company also announced the launch of its SYSTIMAX Constellation edge-based platform.
The insider purchase indicates confidence in the company's prospects, which combined with the launch of a new platform, could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
CEO Sean Dollinger acquired 86,400 shares of LQR House Inc. The company reported the pricing of its IPO at $5.00 per share.
The CEO's purchase of a significant number of shares, along with the pricing of the company's IPO, could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Chief Legal Officer Paul Rivard acquired 150,000 shares of MyMD Pharmaceuticals, Inc. The FDA accepted the company's investigational new drug application for a Phase 2 study.
The insider purchase, along with the FDA's acceptance of the company's new drug application, could have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100